SCWorx (NASDAQ:WORX) Rating Increased to Sell at Wall Street Zen

SCWorx (NASDAQ:WORX) was upgraded by equities research analysts at Wall Street Zen to a “sell” rating in a report issued on Saturday.

SCWorx Price Performance

NASDAQ WORX opened at $0.46 on Friday. The company has a market capitalization of $1.67 million, a price-to-earnings ratio of -0.53 and a beta of 2.37. SCWorx has a 12 month low of $0.39 and a 12 month high of $3.31. The company’s fifty day moving average price is $0.58 and its two-hundred day moving average price is $1.09.

SCWorx (NASDAQ:WORX) last released its quarterly earnings data on Thursday, May 15th. The company reported ($0.25) EPS for the quarter. SCWorx had a negative return on equity of 89.71% and a negative net margin of 108.84%. The business had revenue of $0.72 million during the quarter.

Hedge Funds Weigh In On SCWorx

An institutional investor recently bought a new position in SCWorx stock. Renaissance Technologies LLC bought a new stake in shares of SCWorx Corp. (NASDAQ:WORX) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 20,590 shares of the company’s stock, valued at approximately $35,000. Renaissance Technologies LLC owned 1.11% of SCWorx at the end of the most recent quarter. Hedge funds and other institutional investors own 1.88% of the company’s stock.

SCWorx Company Profile

SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry.